Aging, comorbidity, and reduced rates of drug treatment for diabetes mellitus

Journal of Clinical Epidemiology

Volumn 52, Issue 8, 1999, Pages 781-790

  Glynn, Robert J ^a,b   Choodnovskiy, Igor ^a   Avorn, Jerry ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Aging; Diabetes mellitus; Drug prescriptions; Drug utilization; Nursing homes

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; AGING; ARTICLE; COMORBIDITY; DEMOGRAPHY; DIABETES MELLITUS; DRUG USE; FEMALE; HUMAN; MALE; NURSING HOME; ORAL DRUG ADMINISTRATION; PRESCRIPTION; PRIORITY JOURNAL;

AGE FACTORS; AGED; AGED, 80 AND OVER; COMORBIDITY; DIABETES MELLITUS; DRUG UTILIZATION; FEMALE; HOMES FOR THE AGED; HOSPITALIZATION; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MEDICAID; NEW JERSEY; NURSING HOMES; PROSPECTIVE STUDIES; UNITED STATES;

EID: 0033179303     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(99)00055-4     Document Type: Article

References (49)

1. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 329:1993;977-986.
2. Clark CM Jr, Vinicor F, Editors. Risks and benefits of intensive management in non-insulin-dependent diabetes mellitus: The Fifth Regenstrief Conference. Ann Intern Med 1996; 124: 81-186.
3. Clark C.M. Jr., Lee D.A. Prevention and treatment of the complications of diabetes mellitus. N Engl J Med. 332:1995;1210-1217.
4. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 352:1998;837-853.
5. Nathan D.M. Some answers, more controversy, from UKPDS. Lancet. 352:1998;832-833.
6. American Diabetes Association Standards of medical care for patients with diabetes mellitus. Diabetes Care. 17:1994;616-623.
7. Seltzer H.S. Drug-induced hypoglycemia. a review of 1418 cases Endocrinol Metab Clin North Am. 18:1989;163-183.
8. Shorr R.I., Ray W.A., Daugherty J.R., Griffin M.R. Individual sulfonylureas and serious hypoglycemia in older people. J Am Geriatr Soc. 44:1996;751-755.
9. Chrischilles E.A., Foley D.J., Wallace R.B., Lembe J.H., Semla T.P., Hanlon J.T.et al. Use of medications by persons 65 and over. Data from the Established Populations for Epidemiologic Study of the Elderly J Gerontol. 47:1992;M137-M144.
10. Paganini-Hill A., Ross R.K. Reliability of recall of drug usage and other health-related information. Am J Epidemiol. 116:1982;114-122.
11. Bush T.L., Miller S.R., Golden A.L., Hale W.E. Self-report and medical record report agreement of selected medical conditions in the elderly. Am J Public Health. 79:1989;1554-1556.
12. Fisher E.S., Whaley F.S., Krushat W.M., Malenka D.J., Fleming C., Baron J.A.et al. The accuracy of Medicare's hospital claims data. Progress has been made, but problems remain Am J Public Health. 82:1992;243-248.
13. Jollis J.G., Ancukiewicz M., DeLong E.R., Pryor D.B., Muhlbaier L.H., Mark D.B. Discordance of databases designed for claims payment versus clinical information systems. Ann Intern Med. 119:1993;844-850.
14. McEvoy G.K. American Hospital Formulary Service Drug Information 1996. 1996;American Society of Health System Pharmacists, Bethesda, MD.
15. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies. Development and validation J Chron Dis. 40:1987;373-383.
16. Deyo R.A., Cherkin D.C., Ciol M.A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data. J Clin Epidemiol. 45:1992;613-619.
17. Hosmer D.W., Lemeshow S. Applied Logistic Regression. 1989;John Wiley and Sons, New York.
18. Wetle T. Age as a risk factor for inadequate treatment. JAMA. 257:1987;2766-2770.
19. Mor V., Masterson-Allen S., Goldberg R.J., Cummings F.J., Glicksman A.S., Fretwell M.D. Relationship between age at diagnosis and treatments received by cancer patients. J Am Geriatr Soc. 33:1985;585-589.
20. McLaughlin T.J., Soumerai S.B., Willison D.J., Gurwitz J.H., Borbas C., Guadagnoli E.et al. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction in community hospitals. Evidence for undertreatment in women and the elderly Arch Intern Med. 156:1996;799-805.
21. Kleinman J.L., Donahue R.P., Harris M.I., Finucane F.F., Madans J.H., Brock D.B. Mortality among diabetics in a national sample. Am J Epidemiol. 128:1988;389-401.
22. Muggeo M., Verlato G., Bonora E., Bressan F., Girotto S., Corbellini M. The Verona Diabetes Study. A population-based survey on known diabetes mellitus prevalence and 5-year all-cause mortality Diabetologia. 38:1995;318-325.
23. Geiss LS, Herman WH, Smith PJ. Mortality in non-insulin dependent diabetes. In: National Institute of Diabetes and Digestive and Kidney Diseases, Ed. Diabetes in American 2nd edition. Bethesda, MD: National Institutes of Health; 1995: 233-257. NIH publication no. 95-1468.
24. Kannel W.B., McGee D.L. Diabetes and cardiovascular disease. The Framingham Study JAMA. 14:1979;363-370.
25. Kannel W.B., Vokonas P.S. Demographics and prevalence, incidence, and management of coronary heart disease in the elderly and women. Ann Epidemiol. 2:1992;5-14.
26. Benfante R., Reed D., Frank J. Do coronary heart disease risk factors measured in the elderly have the same predictive roles as in the middle aged. Comparisons of relative and attributable risks Ann Epidemiol. 2:1992;273-282.
27. Klein R., Klein B.E., Moss S.E., Davis M.D., DeMets D.L. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. Arch Ophthalmol. 107:1989;244-249.
28. Young M.J., Boulton A.J., MacLeod A.F., Williams D.R., Sonksen P.H. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 36:1993;150-154.
29. Klein R., Klein B.E., Moss S.E. Relation of glycemic control to diabetic microvascular complications in diabetes mellitus. Ann Intern Med. 124:1996;90-96.
30. Welch H.G., Albertsen P.C., Nease R.F., Bubolz T.A., Wasson J.H. Estimating treatment benefits for the elderly. The effect of competing risks Ann Intern Med. 124:1996;577-584.
31. Kenny SJ, Aubert RE, Geiss LS. Prevalence and incidence of non-insulin dependent diabetes. In: National Institute of Diabetes and Digestive and Kidney Disease, Ed. Diabetes in America, 2nd edition. Bethesda, MD: National Institutes of Health; 1995: 47-67. NIH publication No. 95-1468.
32. Colditz G.A., Willett W.C., Rotnitzky A., Manson J.E. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med. 122:1995;481-486.
33. Geiss L.S., Herman W.H., Goldschmid M.G., DeStefano F., Eberhardt M.S., Ford E.S.et al. Surveillance for diabetes mellitus-United States, 1980-1989. Centers for Disease Control and Prevention. CDC Surveillance Summaries, June 4, 1993. MMWR. 42:1993;. SS-2) 1-20.No.
34. Klein R., Klein B.E., Moss S.E., DeMets D.L., Kaufman I., Voss P.S. Prevalence of diabetes mellitus in southern Wisconsin. Am J Epidemiol. 119:1984;54-61.
35. Sartor F., Walckiers D. Estimate of disease prevalence using drug consumption data. Am J Epidemiol. 141:1995;782-787.
36. Gurwitz J.H., Bohn R.L., Glynn R.J., Monane M., Mogun H., Avorn J. Antihypertensive drug therapy and the initiation of treatment for diabetes mellitus. Ann Intern Med. 118:1992;273-278.
37. Gurwitz J.H., Field T.S., Glynn R.J., Manson J.E., Avorn J., Taylor J.O.et al. Risk factors for non-insulin-dependent diabetes mellitus requiring treatment in the elderly. J Am Geriatr Soc. 42:1994;1235-1240.
38. Melton L.J., Palumbo P.J., Dwyer M.S., Chu D.P. Impact of recent changes in diagnostic criteria on the apparent natural history of diabetes mellitus. Am J Epidemiol. 117:1983;559-565.
39. Harris M.I., Hadden W.C., Knowler W.C., Bennett P.H. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr. Diabetes. 36:1987;523-534.
40. Harris M.I., Flegal K.M., Cowie C.C., Eberhardt M.S., Goldstein D.E., Little R.R.et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994 Diabetes Care. 21:1998;518-524.
41. Iezzoni L.I., Foley S.M., Daley J., Hughes J., Fisher E.S., Heeren T. Comorbidities, complications, and coding bias. Does the number of diagnosis codes matter in predicting in-hospital mortality? JAMA. 267:1992;2197-2203.
42. Glynn R.J., Monane M., Gurwitz J.H., Choodnovskiy I., Avorn J. Agreement between drug treatment and a discharge diagnosis of diabetes mellitus in the elderly. Am J Epidemiol. 149:1999;541-549.
43. Guralnik JM, Fried LP, Simonsick EM, Kasper JD, Lafferty ME, Eds. The Women's Health and Aging Study: Health and Social Characteristics of Older Women with Disability. Bethesda, MD: National Institute on Aging, 1995. NIH publication No. 95-4009.
44. Stolk R.P., Pols H.A., Lamberts S.W., de Jong P.T., Hofman A., Grobbee D.E. Diabetes mellitus, impaired glucose tolerance, and hyperinsulinemia in an elderly population. The Rotterdam Study. Am J Epidemiol. 145:1997;24-32.
45. Meigs J.B., Nathan D.M., Cupples L.A., Wilson P.W., Singer D.E. Tracking of glycated homoglobin in the original cohort of the Framingham Heart Study. J Clin Epidemiol. 49:1996;411-417.
46. Drury TF. Disability among adults. In: National Institute of Arthritis, Diabetes and Digestive and Kidney Disease, Ed. Diabetes in America. Bethesda, MD: National Institutes of Health; 1984. NIH Publication No. 85-1468.
47. Mor V., Murphy J., Masterson A.S. Risk of functional decline among well elders. J Clin Epidemiol. 42:1989;895-904.
48. Mayfield JA, Deb P, Potter DEB. Diabetes and long-term care. In: National Institute of Diabetes and Digestive and Kidney Disease, Ed. Diabetes in America, 2nd Edition. Bethesda, MD: National Institutes of Health; 1995: 571-590. NIH Publication No. 95-1468.
49. Fertig BJ, Simmons DA, Martin DB. Therapy for diabetes. In: National Institute of Diabetes and Digestive and Kidney Disease, Ed. Diabetes in America, 2nd Edition. Bethesda, MD: National Institutes of Health; 1995: 519-540. NIH Publication No. 95-1468.